Publiziert in: Marktpuls, Unternehmen
Frei

New member joins Executive Management in the Ypsomed Group Dienstag, 27. September 2016 - 07:04


27.09.2016

New member joins Executive Management in the Ypsomed GroupMichael Zaugg

Michael Zaugg will join the Executive Management of the Ypsomed Group in mid-April 2017 and take on the role of Senior Vice President Human Resources. He will succeed Yvonne Müller, who is leaving Ypsomed at her own request.

Michael Zaugg is 44 years old and studied Economics at the University of Basel. In his career to-date, he was able to accumulate broad experience in a human resource environment in different positions, among others in the banking and energy sector. Since 2011, he was employed by ABB Switzerland AG with the responsibility of Regional Manager HR Talent for Europe. CEO Simon Michel is delighted with the appointment of Michael Zaugg: "With his proven expertise, Michael Zaugg will be able to significantly shape the strategic and operational development of human resource management at the Ypsomed Group, particularly in terms of international expansion."

Yvonne Müller has been responsible for the Human Resources Department since 2003 and has assured professional and sustainable personnel recruitment, support and development in these 13 years. The Ypsomed Group would like to thank Yvonne Müller for her numerous valuable contributions to the company and wish her all the best for the future

For further information, please contact Benjamin Overney, Head of Investor & Public Relations at Ypsomed Holding AG, by phone at +41 34 424 41 59 or by email (benjamin.overney@ypsomed.com).

About the Ypsomed Group
The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of pens, autoinjectors and infusion systems to administer liquid drugs. Ypsomed promotes and sells its product portfolio under the umbrella brands mylife™ Diabetescare directly to patients or through pharmacies and clinics and under YDS™ Ypsomed Delivery Systems as business-to-business to pharmaceutical companies. Ypsomed has its headquarters in Burgdorf, Switzerland, and operates a global network of manufacturing sites, subsidiaries and distributors. The Ypsomed Group employs around 1’200 employees.